Study | Sample Size, n | Race | Clinical Association |
---|---|---|---|
Reimer, et al9 | 646 SSc, 22 AFA | NA | Lung, heart, and GI involvement |
Okano, et al11 | 416 SSc, 24 AFA | White, African American | Myositis, GI involvement, and PAH |
Jacobsen, et al25 | 230 SSc, 8 AFA | Mostly white | No clinical correlations were found for AFA within this group of patients |
Tormey, et al4 | 1026 SSc, 42 AFA | White, Afro-Caribbean | DcSSc, isolated pulmonary HTN, and myositis |
Aggarwal, et al6 | 2579 SSc, 108 AFA | White, African American | Skeletal muscle involvement and PAH |
Sharif, et al17 | 278 SSc, 52 AFA | All African American | Digital ulcers and lower GI involvement |
Steen, et al15 | 3148 SSc, 114 AFA | White, African American | PAH, GI involvement, and dcSSc |
Nihtyanova, et al26 | 398 SSc, 23 AFA | Mostly white | Pulmonary HTN |
Current study | 1544 SSc, 52 AFA | White, African descent, Native North American, and Australian | DcSSc, GI involvement, and mortality |
AFA: antifibrillarin antibodies; SSc: systemic sclerosis; NA: not applicable; GI: gastrointestinal; HTN: hypertension; dcSSc: diffuse cutaneous SSc; PAH: pulmonary arterial HTN.